Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | GMNN | O75496 | 3/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | BLM | P54132 | 2/20 | 1.00 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 0.97 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.97 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.76 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Palmitoyl-Carnitine SCHEMBL20608769 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL21569424 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22392377 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22206068 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL25375657 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL21114352 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL25373349 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22392372 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL22440886 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN | |
| SCHEMBL19923326 | 1.00 | MAPK1 (1.00) | MAPK1MAPTLMNACYP1A2GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-12458617-B2 | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3709817-B2 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250102528-A1 | METHODS OF ASSESSING CARCASS MUSCLE BIOMARKERS TO DISCRIMINATE CHARACTERISTICS OF THE MEAT | PURDUE RESEARCH FOUNDATION | 2025-03-27 | — | — | US | disclosed |
| US-20230371549-A1 | Pet Food Compositions | HILL'S PET NUTRITION, INC. (US) | 2023-11-23 | — | — | US | disclosed |
| EP-3709817-B1 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2022-11-16 | — | — | EP | disclosed |
| US-20220202759-A1 | Pet Food Compositions Comprising Caprylic Acid and Docosahexaenoic Acid and/or Eicosapetaenoic Acid for Use in Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2022-06-30 | — | — | US | disclosed |
| US-20220208386-A1 | DIAGNOSTIC FOR MATERNAL RISK OF HAVING A CHILD WITH AUTISM SPECTRUM DISORDER | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2022-06-30 | — | — | US | disclosed |
| US-20210369680-A1 | METHODS OF TREATING DISEASES AND DISORDERS RESULTING FROM BETA CORONAVIRUS INFECTION | T3D THERAPEUTICS INC (US) | 2021-12-02 | — | — | US | disclosed |
| US-10973244-B2 | Compositions comprising omega-3 polyunsaturated and medium chain fatty acids | HILLS PET NUTRITION, INC. (US) | 2021-04-13 | — | — | US | disclosed |
| US-20210038654-A1 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING SAME | PERSEPHONE BIOSCIENCES INC. | 2021-02-11 | — | — | US | disclosed |
| US-20200296996-A1 | Compositions Comprising Omega-3 Polyunsaturated and Medium Chain Fatty Acids | HILL'S PET NUTRITION, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| CN-110678175-A | Medium chain fatty acids for the prevention or treatment of cardiac enlargement and/or valvular heart disease | 雀巢产品有限公司 | 2020-01-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | MAPK1 3434/4885MAPT 2558/4885LMNA 1957/4885 |
| US-20210369680-A1 | METHODS OF TREATING DISEASES AND DISORDERS RESULTING FROM BETA CORONAVIRUS INFECTION | PPARD, PPARA, PPARG | MAPK1 1693/4885MAPT 414/4885LMNA 2916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.